Evidence map›Paper›PMID 20173668›Full record

ArticlePancreas2010

Epigenetic regulation affects N-myc downstream-regulated gene 1 expression indirectly in pancreatic cancer cells.

Eliane Angst, David W Dawson, Anne Nguyen, Jenny Park, Vay L W Go, Howard A Reber, Oscar Joe Hines, Guido Eibl

Abstract read
In one paragraph

Article in Pancreas, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Novel therapeutic targets for pancreatic cancer.World journal of gastroenterology · 2014
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Eliane AngstHirshberg Laboratories for Pancreatic Cancer Research, Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. eliane.angst@gmail.com
David W Dawson
Anne Nguyen
Jenny Park
Vay L W Go
Howard A Reber
Oscar Joe Hines
Guido Eibl
Pancreatic Cancer Action Network · US

Funding

UCLA Center for Excellence in Pancreatic DiseasesP01AT003960 · NCCIH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HINES, OSCAR JOE · 2007 to 2011
$5.6M
The role of n-3 polyunsaturated fatty acids in pancreatic cancerR01CA122042 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI EIBL, GUIDO ERWIN MICHAEL · 2007 to 2011
$1.5M
NCCIH NIH HHS P01 AT003960NCCIH NIH HHS P01AT003960NCI NIH HHS R01 CA122042
6 · The paper itself

Abstract

objectivesN-myc downstream-regulated gene 1 (NDRG1), important in tumor growth and metastasis, has recently gained interest as a potential therapeutic target. Loss of NDRG1 expression is generally associated with poor clinical outcome in pancreatic cancer (PaCa) patients. As the NDRG1 gene possesses a large promoter CpG island, we sought to determine whether its repression is epigenetically mediated in PaCa cells.

methodsPancreatic cancer cells were treated with the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine and the histone deacetylase inhibitor trichostatin A. Promoter methylation was assessed by genomic bisulfite sequencing and by combined bisulfite restriction analyses.

resultsTreatment with 5-aza-2'-deoxycytidine and trichostatin A enhanced NDRG1 protein expression, implicating epigenetic regulation of NDRG1. However, there was no significant DNA methylation of the NDRG1 promoter CpG island, as determined by genomic bisulfite sequencing of HPAF-II cells. We further confirmed the lack of promoter methylation in 6 PaCa cell lines by combined bisulfite restriction analyses.

conclusionsThese findings indicate that NDRG1 gene reactivation in PaCa cell lines by pharmacologic reversal of DNA methylation and histone deacetylation occurs via an indirect mechanism. This may occur via the altered expression of genes involved in the regulation of NDRG1 transcription or NDRG1 protein stability in PaCa cells.

Indexed as

Epigenesis, GeneticAzacitidineCell Cycle ProteinsCpG IslandsDecitabineDNA MethylationDNA Modification MethylasesGene Expression Regulation, NeoplasticHistone Deacetylase InhibitorsHumansHydroxamic AcidsIntracellular Signaling Peptides and ProteinsN-myc Downstream-Regulated Gene 1 ProteinPancreatic NeoplasmsPromoter Regions, GeneticTumor Cells, CulturedAzacitidineCell Cycle ProteinsDecitabineDNA Modification MethylasesHistone Deacetylase InhibitorsHydroxamic AcidsIntracellular Signaling Peptides and ProteinsN-myc Downstream-Regulated Gene 1 Proteintrichostatin A

Identifiers

PMID20173668
PMCPMC2895953
OpenAlexW2086286407

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.